 | • レポートコード：MRC2304D079 • 出版社/出版日：Transparency Market Research / 2023年1月25日 • レポート形態：英文、PDF、183ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、急性呼吸窮迫症候群デバイスの世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（治療用デバイス、診断＆モニタリング用デバイス）分析、エンドユーザー別（病院、専門センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを収録しています。また、Koninklijke Philips N.V.、Medtronic、Fisher & Paykel Healthcare Limited、Drägerwerk AG & Co. KGaA、Smiths Medical (ICU Medical)、Hamilton Medical、GE HealthCare、ResMed、Getinge ABなどの企業情報を掲載しています。 ・序論 ・仮定＆調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の急性呼吸窮迫症候群デバイス市場規模：種類別 - 急性呼吸窮迫症候群治療用デバイスの市場規模 - 急性呼吸窮迫症候群診断＆モニタリング用デバイスの市場規模 ・世界の急性呼吸窮迫症候群デバイス市場規模：エンドユーザー別 - 病院における市場規模 - 専門センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の急性呼吸窮迫症候群デバイス市場規模：地域別 - 北米の急性呼吸窮迫症候群デバイス市場規模 - ヨーロッパの急性呼吸窮迫症候群デバイス市場規模 - アジア太平洋の急性呼吸窮迫症候群デバイス市場規模 - 中南米のアルミニウムスラグ市場規模 - 中東・アフリカのアルミニウムスラグ市場規模 ・競争状況 |
Acute Respiratory Distress Syndrome Devices Market – Scope of Report
TMR’s report on the global acute respiratory distress syndrome devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global acute respiratory distress syndrome devices market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute respiratory distress syndrome devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the acute respiratory distress syndrome devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global acute respiratory distress syndrome devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global acute respiratory distress syndrome devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global acute respiratory distress syndrome devices market.
The report delves into the competitive landscape of the global acute respiratory distress syndrome devices market. Key players operating in the global acute respiratory distress syndrome devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global acute respiratory distress syndrome devices market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market acute respiratory distress syndrome devices.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Acute Respiratory Distress Syndrome Devices Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, 2017–2031
5. Key Insight
5.1. Disease Incidence and prevalence
5.2. Key Mergers & Acquisitions
5.3. New Product Launches and FDA Approvals
5.4. COVID-19 Impact Analysis
6. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
6.3.1. Therapeutic Devices
6.3.1.1. Mechanical Ventilators
6.3.1.2. PAP
6.3.1.3. Others
6.3.2. Diagnostic & Monitoring Devices
6.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Type
7. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Specialty Centers
7.3.3. Others
7.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by End-user
8. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Region
9. North America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
9.2.1. Therapeutic Devices
9.2.1.1. Mechanical Ventilators
9.2.1.2. PAP
9.2.1.3. Others
9.2.2. Diagnostic & Monitoring Devices
9.3. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Specialty Centers
9.3.3. Others
9.4. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
10.2.1. Therapeutic Devices
10.2.1.1. Mechanical Ventilators
10.2.1.2. PAP
10.2.1.3. Others
10.2.2. Diagnostic & Monitoring Devices
10.3. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Specialty Centers
10.3.3. Others
10.4. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
11.2.1. Therapeutic Devices
11.2.1.1. Mechanical Ventilators
11.2.1.2. PAP
11.2.1.3. Others
11.2.2. Diagnostic & Monitoring Devices
11.3. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Specialty Centers
11.3.3. Others
11.4. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
12.2.1. Therapeutic Devices
12.2.1.1. Mechanical Ventilators
12.2.1.2. PAP
12.2.1.3. Others
12.2.2. Diagnostic & Monitoring Devices
12.3. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Specialty Centers
12.3.3. Others
12.4. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
13.2.1. Therapeutic Devices
13.2.1.1. Mechanical Ventilators
13.2.1.2. PAP
13.2.1.3. Others
13.2.2. Diagnostic & Monitoring Devices
13.3. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Specialty Centers
13.3.3. Others
13.4. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis By Company (2021)
14.3. Company Profiles
14.3.1. Koninklijke Philips N.V.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Medtronic
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Fisher & Paykel Healthcare Limited
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Drägerwerk AG & Co. KGaA
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Smiths Medical (ICU Medical)
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Hamilton Medical
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. GE HealthCare
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.8. ResMed
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Getinge AB
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview